Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their...

Area of Science:

• Pediatric infectious diseases
• Cardiology
• Immunology

Background:

• Multisystem inflammatory syndrome in children (MIS-C) is a serious condition following SARS-CoV-2 infection.
• MIS-C typically manifests 2-4 weeks post-infection with signs of inflammation and cardiac dysfunction.
• Current treatments for MIS-C during the acute phase require further research for safety and effectiveness.

Purpose of the Study:

• To review the potential of natural compounds in managing MIS-C.
• To explore antioxidant and anti-inflammatory properties of natural compounds for MIS-C treatment.
• To identify novel therapeutic interventions for reducing hyperinflammation-related damage in MIS-C.

Main Methods:

• Literature review of existing studies on MIS-C.
• Analysis of research on natural compounds with anti-inflammatory and antioxidant effects.
• Synthesis of findings to propose potential treatment strategies for MIS-C.

Main Results:

• MIS-C is characterized by significant inflammation and potential cardiac complications post-SARS-CoV-2.
• Natural compounds possess antioxidant and anti-inflammatory properties that may counteract MIS-C pathology.
• Evidence suggests natural compounds could mitigate collateral damage from hyperinflammation.

Conclusions:

• Natural compounds offer a promising avenue for novel MIS-C treatments.
• Targeting hyperinflammation with natural agents may reduce MIS-C severity.
• Further research into natural compounds is crucial for developing effective MIS-C interventions.